Nuvectis Pharma, Inc. — Director's Dealing 2025

Oct 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-09-22

Reporting Person: Sanchez Juan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-22	Common Stock	A	30000	—	Acquired	65150	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	415	Indirect

Footnotes

F1: The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Dr. Sanchez's continued service on the Company's Board of Directors on such dates.